Novo Nordisk shares dive 9% after heart medicine fails trial - CNBC
Source:CNBC
The experimental medicine ziltivekimab didn’t translate into a statistically meaningful reduction in major cardiovascular adverse events, Novo said Friday.
Related Articles
A symbol of peace was cut from US dimes. Is it a message from Trump? - Yahoo
The design was finalized in 2024, before Trump took office. The artist and U.S. Mint say it …
Doris Fisher, Gap cofounder, dies at 94 - The San Francisco Standard
Fisher, who started the fashion brand with her late husband, was a San Francisco native.
Stock futures tick higher after S&P 500 erases Iran war losses: Live updates - CNBC
Wall Street once again proved resilient in the face of increased geopolitical uncertainty.
‘I Actually Thought He Was Going to Hit Me,’ OpenAI’s Greg Brockman Says of Elon Musk - WIRED
OpenAI’s president wrapped his testimony on Tuesday by revealing a fiery meeting with Musk in 2017 …